skip to main content

S. 916: Protecting Patient Access to Emergency Medications Act of 2017

A bill to amend the Controlled Substances Act with regard to the provision of emergency medical services.

The bill’s titles are written by its sponsor.

What you can do

Overview

Introduced:

Apr 24, 2017

Status:

Ordered Reported on Apr 26, 2017

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on April 26, 2017.

Sponsor:

Bill Cassidy

Senior Senator from Louisiana

Republican

Text:

Read Text »
Last Updated: May 1, 2017
Length: 34 pages

Prognosis:

4% chance of being enacted according to Skopos Labs (details)

History

Apr 24, 2017
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Apr 26, 2017
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Pending
 
Passed Senate (House next)

Pending
 
Passed House

Pending
 
Signed by the President

S. 916 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 916 — 115th Congress: Protecting Patient Access to Emergency Medications Act of 2017.” www.GovTrack.us. 2017. September 22, 2017 <https://www.govtrack.us/congress/bills/115/s916>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.